Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male

NCT00028990 2023-06-15

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Phase 3 Completed

722 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00089323 2021-10-11

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

Phase NA Completed

1,630 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00911716 2019-08-01

TC Avastin. ICORG 08-10, V6

Phase NA Completed

106 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00410813 2017-07-02

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

Phase 2 Completed

85 enrolled 18 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT00937417 2017-04-24

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

Phase 1 Withdrawn

BreastCNSEndocrineGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

NCT00217659 2013-01-03

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00068757 2012-09-12

Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Phase 1 Completed

23 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

Clinical Trials

e3

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

LAPATAM

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer

TC Avastin. ICORG 08-10, V6

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer